On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Nanocell Therapeutics B.v.'s own share of each project, not the project's full budget.
- Horizon Europe€3.5M · 2 projects
Projects
2 EU-funded projects, newest first. Nanocell Therapeutics B.v. led 1 of them as coordinator. Each links to the official record.
- NANOCARCoordinator
Revolutionizing Blood Cancer Therapy: Next-Gen CAR-T Therapy with In Vivo Nanoparticle Targeting
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€2.3Mtheir share - NANO-ENGINEPartner
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€1.1Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Imperial College of Science Technology and MedicineUnited Kingdom · 1 shared project
- Universiteit UtrechtNetherlands · 1 shared project
- Karolinska InstitutetSweden · 1 shared project
- SINTEF ASNorway · 1 shared project
- Qsar Lab Spolka Z Ograniczona OdpowiedzialnosciaPoland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- gene therapy
- nano-materials
- nanomedicine
- nucleic acids
- oncology
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.